Læknablaðið - 15.09.2000, Blaðsíða 57

FRÆÐIGREINAR / LÍFFÆRAFLUTNINGAR
5. Antin JH, Smith BR. Bone Marrow Transplantation. In:
Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and
Practice of Hematology. Philadelphia: J.B. Lippincott
Company; 1995:2055-60.
6. Goldman JM, Schmitz N, Niethammer D, Gratwohl A.
Indications for stem cell transplantations. In: Apperley JF,
Gluckman E, Gratwohl A, eds. The EBMT Handbook. Blood
and Marrow Transplantation. Paris: European School of
Haematology; 2000: 57-67.
7. Vogelsang G. Bone marrow transplantation. In: Jacob H, ed.
Hematology MKSAP. 2nd ed. Philadelphia: American society
of Hematoiogy American College of Physicians - American
Society of Internal Medicine; 1999: 51-65.
8. Bone Marrow Donors Worldwide [cited 2000 July 21]:
http://www.BMDW.ORG
9. Bensinger W, Martin P, Clift R, Storer B, Forman S, Blume K,
et al. A prospective randomized trial of peripheral blood stem
cells (PBSC) or marrow (BM) for patients undergoing
allogeneic tansplantation for hematologic malignancies. Blood
1999; 94: 368a.
10. Armitage S, Warwick R, Fehily D, Navarrete C, Contreras M.
Cord blood banking in London: the first 1000 collections.
Bone Marrow Transplantation 1999; 24:139-45.
11. Sullivan KM. Graft-Versus-Host Disease. In: Thomas ED,
Blume KG, Forman SJ, eds. Hematopoietic cell
transplantation. Útgáfustaöur: Blackwell Science Inc.; 1999;
515-36.
12. Mathe G, Amiel JL, Schwarzenberg L, Cattan A,Schneider M.
Haematopoietic chimera in man after allogenic (homologous)
bone-marrow transplantation (Control of the secondary
syndrome. Specific tolerance due to the chimerism). BMJ
1963; 5373:1633-5.
13. Billingham RE. The biology of graft-versus-host reactions.
The Harvey lectures. Vol. 62. New York: Academic Press;
1966: 21-78.
14. Rodney GE, Lalezari P. HLA and Neutrophil Antigens and
Antibody Systems. In: Hoffman R, Benz EJ, Shattil SJ, Furie
B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology,
Basic Principles and Practice. 3rd ed. Útgáfustaður: Churchill
Livingstone; 2000: 2220-41
15. Antin JH. Inhibition of dysregulated cytokines to control
acute graft-versus-host disease. Hem/Onc Annals 1994; 2:341-
7.
16. Martin PJ. Overview of Marrow Transplantation Immunology.
In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic
cell transplantation. Útgáfustaður: Blackwell Science Inc.;
1999; 19-27.
17. Ferrara JLM. The cytokine modulation of acute graft-versus-
host disease. Bone Marrow Transplantation 1998; 21/Suppl. 3:
13-5.
18. Carlens S, Ringdén O, Remberger M, Lönnqvist B, Hágglund
N, Klaesson S, et al. Risk factor for chronic graft-versus-host
disease after bone marrow transplantation: a retrospective
single centre analysis. Bone Marrow Transplantation 1998; 22:
755-61.
19. Weiden PL, Flournoy N, Thomas ED. Anti-leukemic effect of
graft-versus-host disease in human recipients of allogeneic-
marrow grafts. N Engl J Med 1979; 300:1068-73.
20. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B,
Jacobsen N, Arcese W, et al. Graft-Versus-Leukemia Effect of
Donor Lymphocyte Transfusions in Marrow Grafted patients.
Blood 1995; 86: 2041-50.
21. Bacigalupo A. Hematopoietic stem cell transplants after
reduced intensity conditioning regimen: report of a workshop
of the EBMT. Bone Marrow Transplantation 2000; 25: 03-805.
22. Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M,
Burnison M, et al. Bone marrow transplantation for severe
aplastic anemia: effect of a preparative regimen of
cyclophosphamide- low- dose total- lymphoid irradiation and
postransplant cyclosporine- methotrexate therapy.
Transplantationl990; 49: 720-4.
23. Ribaud P. Early complications. In: Apperley JF, Gluckman E,
Gratwohl A, eds. The EBMT Handbook. Blood and Marrow
Transplantation, Paris: European School of Haematology;
2000:153-63.
24. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G,
Travis LB, et al. Solid cancers after bone marrow
transplantation. N Engl J Med 1977; 336: 897-904.
25. Gratwohl A, Hermans J. Outcome of Blood and Marrow
Transplants. In: Apperley JF, Gluckman E, Gratwohl A, eds.
The EBMT Handbook. Blood and Marrow Transplantation.
Paris: European School of Haematology; 2000:111-8.
26. Hansen JA, Gooley TA, Martin PJ. Bone marrow transplants
from unrelated donors for patients with chronic myeloid
leukemia. N Engl J Med 1998; 338: 962-8.
27. Jensdóttir M, Haraldsdóttir V, Björnsdóttir J, Jónmundsson
GK, Reykdal S. Mergskipti og eigin stofnfrumuflutningur.
Árangur meðferðar íslenskra sjúklinga 1981-1999 [ágrip].
Læknablaðið 2000; 86/Fylgirit 39:32-3.
Læknablaðið 2000/86 599